IAEA Resource Listings
2022
Worldwide Disparities in Recovery of Cardiac Testing 1 Year into COVID-19
EINSTEIN, A.J. et al., Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19, Journal of the American College of Cardiology, Vol. 79, Elsevier BV (2022) pp. 2001–2017
2022
COVID-19 Impact on the Diagnosis of Cardiac Disease in Latin America an INCAPS COVID Sub-analysis
CERCI, R.J. et al., The Impact of COVID-19 on Diagnosis of Heart Disease in Latin America an INCAPS COVID Sub-analysis, Arquivos Brasileiros de Cardiologia, Sociedade Brasileira de Cardiologia (2021)
2021
Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)
DONDI, M., et al., Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID), Int J Cardiol (2021)
2021
Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)
O'SULLIVAN, P., et al., Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID), Heart Lung Circ 30 10 (2021) 1477-1486.
2021
Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe
WILLIAMS, M.C., et al., Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe, Open Heart (2021) 2021.
2021
Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World: The INCAPS-COVID Study
HIRSCHFELD, C.B., et al., Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World: The INCAPS-COVID Study, JACC Cardiovasc Imaging (2021)
2021
Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study
INTERNATIONAL ATOMIC ENERGY AGENCY, Training Curriculum for Nuclear Medicine Physicians IAEA, Vienna (2019)pp.
2021
Worldwide Diagnostic Reference Levels for Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Findings From INCAPS
HIRSCHFELD, C.B., et al., Worldwide Diagnostic Reference Levels for Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Findings From INCAPS, JACC Cardiovasc Imaging (2020)
2021
Programmes of the International Atomic Energy Agency for Nuclear Cardiology and Quality Management
DONDI, M., PAEZ, D., SURESHKUMAR, S., Programmes of the International Atomic Energy Agency for Nuclear Cardiology and Quality Management, Nuclear Cardiology Basic and Advanced Concepts in Clinical Practice, Springer International Publishing, (2021).
2020
Clinical and gated SPECT MPI parameters associated with super-response to cardiac resynchronization therapy
MESQUITA, C.T., et al., Clinical and gated SPECT MPI parameters associated with super-response to cardiac resynchronization therapy, J Nucl Cardiol (2020)
2020
Intraventricular synchronism assessment by gated-SPECT myocardial perfusion imaging in cardiac resynchronization therapy. Does cardiomyopathy type influence results?
PEIX, A., et al., Intraventricular synchronism assessment by gated-SPECT myocardial perfusion imaging in cardiac resynchronization therapy. Does cardiomyopathy type influence results?, EJNMMI Res 10 1 (2020) 125.
2020
Reproducibility of global LV function and dyssynchrony parameters derived from phase analysis of gated myocardial perfusion SPECT: A multicenter comparison with core laboratory setting
DE AMORIM FERNANDES, F., et al., Reproducibility of global LV function and dyssynchrony parameters derived from phase analysis of gated myocardial perfusion SPECT: A multicenter comparison with core laboratory setting, J Nucl Cardiol (2020)
2019
ASNC and EANM Cardiac Amyloidosis PRACTICE POINTS (2019)
The purpose of this document is to identify the critical components involved in performing 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) or 99mTechnetium-hydroxymethylene diphosphonate (99mTc-HMDP) imaging for the evaluation of cardiac transthyretin amyloidosis